HPV Vaccine Significantly Reduces Cervical Precancer in Young U.S. Women
A Centers for Disease Control and Prevention report shows an approximately 80% reduction in cervical precancerous cells among 20- to 24-year-old women in the U.S. between 2008 and 2022, strongly correlating with the introduction of the HPV vaccine in 2006.
HPV Vaccine Significantly Reduces Cervical Precancer in Young U.S. Women
A Centers for Disease Control and Prevention report shows an approximately 80% reduction in cervical precancerous cells among 20- to 24-year-old women in the U.S. between 2008 and 2022, strongly correlating with the introduction of the HPV vaccine in 2006.
Progress
52% Bias Score
HPV Vaccine Shows Promise in Eliminating Cervical Precancer
A Dutch trial found that an HPV vaccine (Vvax001) eliminated high-risk cervical precancerous cells (CIN3) in half of 18 participants, potentially replacing the invasive loop excision surgery; after 19 weeks, nine saw their cells shrink or vanish, with three cases showing complete destruction, and no...
HPV Vaccine Shows Promise in Eliminating Cervical Precancer
A Dutch trial found that an HPV vaccine (Vvax001) eliminated high-risk cervical precancerous cells (CIN3) in half of 18 participants, potentially replacing the invasive loop excision surgery; after 19 weeks, nine saw their cells shrink or vanish, with three cases showing complete destruction, and no...
Progress
40% Bias Score
Global Push to Eliminate Cervical Cancer
Global Day of Action for Cervical Cancer Elimination urges G20 leaders to increase access to vaccines, screening, and treatment to eliminate cervical cancer.
Global Push to Eliminate Cervical Cancer
Global Day of Action for Cervical Cancer Elimination urges G20 leaders to increase access to vaccines, screening, and treatment to eliminate cervical cancer.
Progress
32% Bias Score
HPV Vaccine Significantly Reduces Cervical Cancer Risk in Young Women
The CDC reports an 80% reduction in precancerous cervical lesions among vaccinated 20-24 year-old women from 2008-2022, contrasting with US Health Secretary Robert Kennedy Jr.'s stance against the HPV vaccine, despite his financial ties to lawsuits against the vaccine manufacturer.
HPV Vaccine Significantly Reduces Cervical Cancer Risk in Young Women
The CDC reports an 80% reduction in precancerous cervical lesions among vaccinated 20-24 year-old women from 2008-2022, contrasting with US Health Secretary Robert Kennedy Jr.'s stance against the HPV vaccine, despite his financial ties to lawsuits against the vaccine manufacturer.
Progress
40% Bias Score
China Approves HPV Vaccine for Males
On January 9th, 2025, China administered its first HPV vaccine dose to a man in Changsha, Hunan province, expanding access to Merck's Gardasil vaccine for males aged 9-26 to prevent HPV-related cancers and genital warts.
China Approves HPV Vaccine for Males
On January 9th, 2025, China administered its first HPV vaccine dose to a man in Changsha, Hunan province, expanding access to Merck's Gardasil vaccine for males aged 9-26 to prevent HPV-related cancers and genital warts.
Progress
36% Bias Score